Market Size (2016)
$3.08B
Vertical: HealthcareBase Year: 201613 Sections
Market Size (2016)
$3.08B
Projected (2023)
$3.81B
CAGR (2014–2023)
3.1%
Key Players
7+
Suturing is a technique used to close cutaneous wounds. The prime goals of this technique includes closing dead spaces, reducing the risks of bleeding, strengthening wounds until healing, and making skin aesthetically pleasing. Various type of suture needles are available in the market such as, taper point needle, spatula needle, coronar tip needle, taper cutting, triangle needle, and others. Sometimes, the principle of choosing a suture needle also depends upon the type of tissue. For instance, taper point needles are usually preferred to suture tissues that are effortless to penetrate whereas tapercut or cutting needles are used for hard tissues.
Notably, rising number of surgical procedures and favourable reimbursement scenario for a number of surgical procedures are promoting the growth of suture needles market globally. Road accidents have found to be responsible for rising surgical procedures and occurrence of wounds due to injuries. For instance, according to a study published in the Journal of Injury and Violence Research in 2017, it is found that low and middle-income countries bear the major burden of road traffic incidents worldwide.
Despite these drivers, there are some issues associated with suture needles market. Increasing incidence of needle stick injuries and easy availability of alternatives may hinder the growth of market.
Geographically, Americas region is commanding the largest market share owing to the improvement in reimbursement policies and rising healthcare expenditure. According to the American Medical Association, Medicare has made various significant amendments in Ambulatory Surgery Center payment system (ASC).
The global suture needles market is expected to reach USD 3,809.4 million by 2023 from USD 3,076.5 million in 2016. This market is expected to grow at a stable CAGR of 3.1% during the forecast period 2017-2023.
On the basis of shape, the global suture needles market is classified into straight, j shape, compound curve, half curved, and others. In 2016, straight needles segment commanded the largest market share of 25.4% and half curved needle is expected to grow at a fastest CAGR of 3.5% during the forecast period 2017 to 2023.
On the basis of type, the global suture needles market is classified into eyed and eyeless. Eyeless segment commanded the largest market share of 55.7% in 2016, and this segment is also expected to grow at a fastest CAGR of 3.4% during the forecast period 2017 to 2023.
The Suture Needle Market market is projected to grow at a CAGR of 3.1% from 2014 to 2023.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansSubscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansSuture Needle Market
Historical performance and future projections (2020–2030, USD Billion)
Market Size (USD Mn)
Research Objective
To provide detailed analysis of the market structure along with forecast of the various segments and sub-segments of global suture needle market.
To provide comprehensive analysis of suture needle industry and its sub-segments in the global market, thereby providing a detailed structure of the industry. To provide detailed insights into the factors driving and restraining the growth of global suture needle market.To estimate the market size of global suture needle from 2014 to 2023. Wherein, 2014 & 2015 would be the historic period, 2016 shall be the base year, and 2017 – 2023 will be forecast period for the study.To analyze global suture needle market, on the basis of four main geographies namely, Americas, Europe, Asia-Pacific, and Middle East & Africa.To compare the products with respect to the various players in the marketTo provide country wise market value analysis for various segments of suture needle marketTo understand the demand-supply scenario and provide gap analysis of the industryTo analyze and provide upcoming technologies and trends in suture needle marketTo provide strategic profiling of key companies (manufacturers and distributors) present across the globe, and comprehensively analyze their competitiveness/competitive landscape in this market.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansSubscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansSubscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansThis report applies a rigorous multi-stage research process combining primary interviews, secondary data sources, and bottom-up market modelling to ensure accuracy and completeness across all segments and geographies.
Base Year
2016
Historical Period
2014 – 2015
Forecast Period
2017 – 2023
Primary Interviews
150+
Historical data (2014–2016) and forecast period (2016–2023)
Our research process spans primary interviews with industry stakeholders combined with comprehensive secondary data analysis, validated through triangulation across multiple independent sources.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansVarious major players are working in the development of Suture Needles market. Through extensive research, it is found out that the market players have adopted the strategy of development of newly developed technology, agreements, acquisitions and collaborations.
Many leading players are concentrated in the global Suture Needless market owing to a demanding market these players have expanded their market in other region as well. The major companies operating in the market are Hill-Rom, Medtronic plc. B. Braun Melsungen AG, Johnson & Johnson Services, Inc., which account for a market share of around ~55% in 2016. Medtronic plc. are one of the leading players in the market with huge global presence and efficient products portfolio.
Bargaining Power of Suppliers
The suppliers in the global suture needles industry are the developers and manufacturers of suture needles. Currently, a number of suppliers are present in the market due to the availability of huge opportunities for the development, huge demand, and increasing government support. Currently, the market consists of large number of players manufacturing suture needles, however, few existing key companies capture significant share in the global market and have the capability of fluctuating the costs of the devices. Switching cost of these suppliers is medium because suppliers tend to enter into long-term associations, partnership, and deals with the other device manufacturing companies. The overall bargaining power of suppliers in the global suture needles market is medium.
Bargaining Power of Buyers
The bargaining power of the buyers is medium to high in the global suture needles market due to the presence of huge number of device providers in the industry. Because of the difference in the services and products provided by the manufacturer, the buying power of the buyer increasing with increasing number of choices of the products. Thus, the number of manufacturers increases the selection arena of the sellers for the buyers, which leads to the high bargaining power. However, the buyers tend to use the products that have been provided by the top players irrespective of the pricing, which affects the power of a buyer in the industry.
Threat of New Entrants
The threat of new entrants is medium in the global suture needles market due to developing the potential market. Any manufacturing company is trying to enter the market is required to accept the mandatory regulatory standards issued by government authorities. Moreover, the technological advancements in the industry are more likely to attract new companies to enter the business. The rise in the demand for the curved suture needle into the market owing to its potential growth in the coming future is expected to attract the currently established and other manufacturers to focus more on this segment. There is a strong hold of the big companies in the global market, which can make the entry of the new players a bit difficult.
Threat of Substitutes
The threat of substitutes in the global suture needles market is pretty high. Buyer’s propensity to substitute is high due to great availability of substitutes in this market. However, quality and trust issue for the products provided by the new players, and excellent service provided by the existing players may restrict the threat by the substitutes to an extent. Also, the low-medium degree of switching cost may minimize the threat of substitutes.
Intensity of Rivalry
The degree of competition in the global suture needles market is considered to be high. Differentiation among existing players and introduction of the newer products is increasing the intensity of rivalry in the market. Suture needles manufacturing companies are trying to develop products with high quality, services, and enhanced safety to increase the demand for these products in developed countries and developing regions. To overcome the competition, players are engaged in partnering with the established organizations and welcoming tie-ups. Moreover, the players are also developing advanced products for differentiating their brand from competitors.
Market estimates by geography (2023)
InsightEurope leads with $1.11B by 2023, while North America is projected to grow fastest at a 3.7% CAGR.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription Plans| REGION | 2014 | 2016 | 2023 | CAGR | SHARE |
|---|---|---|---|---|---|
| Asia Pacific | $599.10M | $708.40M | $810.10M | 3.4% | 21% |
| Europe | $833.50M | $975.90M | $1.11B | 3.2% | 29% |
| Middle East and Africa | $497.80M | $553.20M | $600.70M | 2.1% | 16% |
| South America | $200.50M | $217.80M | $231.20M | 1.6% | 6% |
| North America | $763.30M | $916.20M | $1.06B | 3.7% | 28% |
| Total | $2.89B | $3.37B | $3.81B | 3.1% | 100% |
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansTotal Market Size
$3.81B
| APPLICATION | REVENUE ($B) | GROWTH RATE | MARKET PENETRATION |
|---|---|---|---|
| Straight | $988.20M | 3.4% | 26% |
| half curved | $918.90M | 3.5% | 24% |
| J Shape | $666.40M | 3.3% | 17% |
| Others | $636.00M | 1.8% | 17% |
| Compound curve | $599.90M | 3.2% | 16% |
* Revenue projections based on 2025 estimates. Growth rates represent CAGR 2024–2030. Market penetration indicates current adoption rate within addressable market segments.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansSee plans for professionals or small and medium businesses.

Analytical insights on Suture Needle Market covering market dynamics, competitive landscape, and strategic outlook.
The Suture Needle Market market is projected to reach $3.81B by 2023, growing at 3.1% CAGR. The Straight segment holds the largest share.
Suture needles plays an important role in the placement of sutures in tissues. Sometimes, the principle of choosing a suture needle also depends upon the type of tissue. For instance, taper point needles are usually preferred to suture tissues that are effortless to penetrate whereas tapercut or cutting needles are used for hard tissues.
The suture needles market is expecting a stable growth during the forecasted period 2017-2023. The major driving factors for the market are increasing number of surgical procedures, and improvement in reimbursement policies. However, easy availability of alternatives, and rising number of needle stick injuries may hamper the market growth in coming future.
Facts & InformationWith the rising limiest of chronic diseases, need of surgical procedures has also been escalatingAs per the 2015 statistics suggested by Eurostat, cataract sugary, and colonoscopy were the two most common surgical procedures performed in European region. It is observed that in the year 2015, cataract sugary way performed one thousand times per 100,000 inhabitants specifically in Germany, Sweden, the Czech Republic, Luxembourg, Finland, Malta, Estonia, Austria, Portugal and France. Other common procedures include bronchoscopies, and transluminal coronary angioplastiesAccording to the Australian Institute of Health and Welfare, during 2015-16, there were 10.6 million hospitalization, and 1 in 4 hospitalization involved a surgical procedureAmerican Society of Plastic Surgeons stated that in the year 2016, around 1,780,987 cosmetic surgical procedures were performedRoad accidents hare also found to be responsible for rising surgical procedures, and occurrence of wounds due to injuries. For instance, according to a study published in the Journal of Injury and Violence Research it 2017, it is fond that low and middle income countries bear the major burden of road traffic incidents worldwideA study published in the International Journal of Contemporary Pediatrics, in 2016, stated that during 2014 to 2016, 195 children were admitted for road traffic accident in India and around 6.7% went through surgical procedure for complex injury
Interpretation
Suturing is an indispensable process during injury, incision or surgery as it helps in wound healing. For different wounds or surgical procedures distinct stitching styles have been used such as vertical mattress, layered closure, horizontal mattress, running suture, and many others. Demand for surgical procedures is on rise across the globe as surgery has become standard treatment for various health conditions
Impact
Suture needles market is expected to showcase tremendous growth on account of the rising number of surgical procedures as in most common surgeries suturing is an important aid for wound closure
Growth Enhancement Factor
This is an important aid in various surgical procedures such as endoscope assisted sugary, cosmetic plastic sugary, bariatric surgery, and others. The increasing number of surgical procedures is expected to escalated the demand for suture needles
Conclusion
The primary goals of suturing are reducing the risks of bleeding, closing dead space, strengthening wounds until healing, and to attain aesthetically pleasing and functional results.
Fact & Information
Suturing is the most common method used for the ulcer wound managementAccording to a 2016 study published in Wound Repair and Regeneration, it is found that occurrence of venous leg ulcers (VLU) is three to four times higher in population older than 80 years. Incidence of pressure ulcers (PU) five to seven times higher in people older than was as compared to 65 to 70 years old populationIt is also reported that care for chronic wound costs around USD 10 billion annually, and would care in persons aged 65 and older accounts for the majority of these costsAccording the report of WHO published in 2015, the geriatric population is excepted to double and reach 2.1 billion by 2050
Interpretation
Older adults are more vulnerable towards chronic wounds than younger people, and also wound healing slows with age.
Fact & Information
There is continuous surge for the adoption of technologically advanced suturing productsIn past few years various alternatives of suture needles have come forward such as staples, tapes, tissue adhesives, and othersBioWeld1 system by lonMed is a cold plasma system designed for surgical incision closureEthicon has also introduced various suturing products such as Dermabond Advanced Topical Skin Adhesive, and others
Interpretation
In past fay years various technologically advanced suturing products have been introduced in the market.
Pricing is one of the most important factors for a product to withstand in the market. The importance is not given to what customer’s likes, but rather what they are ready to pay, which, in turn, generate maximum profit or revenue or market share of the overall industry. Currently, major companies are focusing on the cost-effectiveness of nerve stimulators across the globe, especially, developing region like Asia Pacific, where individuals cannot afford the high cost of the products. The increasing prevalence of the multiple chronic diseases is motivating government authorities in developing countries to support the manufacturer for the development of the new and advanced devices.
Suturing is a foremost component of wound care resulting from surgery or other procedures, and wounds occur due to serious injuries. The main goals of suturing are effective hemostasis, faster wound healing, and improvement of issue functioning, and appearance.
Across the globe, health systems are developing in response to multiple factors such as new medical technology, new health services, changes in health policies, new organizational structures, innovations in drug development, and greater access to health services.
Owing to the rising number of surgical procedures various insurance companies, and other associations are amending and improving the coverage policies. For instance, in 2017, Medicare made various changes in Ambulatory Surgery Center payment system (ASC). As per the recent surgery Medicare updates, in 2016 Ambulatory Surgery Center fee schedule for repair of anorectal fistula with plug, repair recurrent incisional, and repair recurrent incisional or ventral hernia was USD 1,301.02, USD 1,460.91, and USD 1,460.91 respectively which is now increased to USD 1,113.05, USD 2,037.05, and USD 2,037.05.
According the report suggested by U.S. Centers for Medicare & Medicaid Services, in the year 2016, U.S. health care spending had increased by 4.3 percent i.e., USD 3.3 trillion, and USD 10,348 per person. Out of this amount, 32 % share was of hospital care, 20 % for physician and clinical services, 10% for prescription drugs, 3% for other professional services, 4% for dental services, 2% for durable medical equipment, and others.
According to the data suggested by Eurostat, it is observed that among the EU Member States, the highest value of healthcare expenditure was recorded in Germany in 2014 i.e. EUR 321 billion which is further followed by France with EUR 237 billion, and United Kingdom with EUR 223 billion.
According to the Australian Institute of Health and Welfare, during 2015–16, the total health expenditure was USD 170.4 billion, which is 3.6% higher than expenditure of 2014–15. Out of this, government health expenditure was USD 114.6 billion, around 67.3% of total health expenditure. During the same years, Non-government sources spent USD 55.8 billion on health. Despite the great economic development in the Asia-Pacific region, some part of the region are still facing inadequate health expenditure due to unequal distribution of resources.
Near-term growth will likely concentrate in modular bioreactor lines and closed-system media workflows that shorten validation cycles while preserving batch traceability.
Partnerships between CDMOs and instrumentation vendors should accelerate standard datasets for comparability across sites, improving forecasting models used in capacity planning.
Longer horizon, organoid and microphysiological adoption may reshape segment mix; teams that invest early in assay interoperability and cloud QC hooks are better positioned to capture upside without fragmenting their analytics stack.
Profiles of 102 companies operating in the Suture Needle Market market, including revenue, employee count, and market positioning where available.
Showing 102 of 102 companies
Roboz Surgical Instrument
Company Headquarter: Gaithersburg, Maryland, United States Workforce: 11-50 employees Company Working: Roboz Surgical Instrument company is engaged in the wholesale distribution of surgical and other instruments, apparatus, and equipments.
B. Braun Melsungen AG
Novavax, Inc.
Company Headquarters: Maryland, US Founded: 1987 Workforce: ~2,500 Company Working: Novavax, Inc. is a biotechnology company that commercializes and develops vaccines to prevent a wide range of infectious diseases. It designs recombinant nanoparticle vaccine technology that produces a strong immune response against a variety of pathogens. It is partnered with leading biopharma organizations, government agencies, research institutions, and foundations, namely the Coalition for Epidemic Preparedness Innovations (US), the Joint Program Executive Office for Chemical, Biological, Radiological, and Nuclear Defense (US), the Serum Institute of India Pvt. Ltd. (India), SK Bioscience (South Korea), CPL Biological (India), and Takeda Pharmaceuticals (US). It has seven research and manufacturing facilities. It has presence in regions namely North America, Europe, and the Middle East and Africa
Cleveland Biolabs, Inc
Company Headquarters: New York, US Founded: 2003 Workforce: ~150 Company Working: Cleveland Biolabs, Inc. is an innovative biopharmaceutical company developing products to address immune system diseases and serious medical needs. It is specialized in offering products such as radiation injury products, immune-oncology, and orphan drugs. It has nine product candidates in its pipeline that have been developing directly through itself or its wholly owned companies, namely Incuron, LLC (US) and Panacela Labs, Inc. (US). It has a proprietary platform, namely the Advanced Immunomodulating Multi-Receptor System (AIMS) platform, which is designed to restore immune homeostasis. Moreover, it has collaboration with government agencies which supports the advanced development and procurement of new medical countermeasures including drugs, vaccines, diagnostics, and medical supplies in order to protect public health from chemical, biological, radiological, and nuclear threats.
SIGA Technologies
Company Headquarters: New York, US Founded: 1995 Workforce: ~50 Company Working: SIGA Technologies (SIGA) is a pharmaceutical business at the commercialization stage that develops and offers antiviral treatments for smallpox, monkeypox, cowpox, and vaccinia complications. The company has an established research and development collaboration with US federal entities. It provides countermeasures to the Strategic National Stockpile (SNS) and the Department of Defense (DoD). TPOXX ("oral TPOXX," also known as "tecovirimat" in certain overseas markets) is the Company's lead product, which it distributes to the US government and international governments (including government-affiliated entities). In addition, the Company sells TPOXX intravenous formulation ("IV TPOXX") to the US Government
Altimmune
Company Headquarters: Maryland, US Founded: 1997 Workforce: ~50 Company Working: Altimmune is a clinical-stage biopharmaceutical business focusing on treating obesity and liver illnesses. The business is working on HepTcell, an immunotherapeutic drug aimed at providing a functional cure for chronic hepatitis B. The company was formed through the merger of PharmAthene, Inc. ("PharmAthene") with the company formerly known as Altimmune
12 interactive charts drawn from the Suture Needle Market dataset — market size, regional splits and each segment breakdown. Open one to read its full data table and download it.
Global Suture Needle Market United States and Canada Of North America By Country
Global Suture Needle Market South America Of South America
Global Suture Needle Market Rest Of Middle East And Africa, Saudi Arabia, UAE, Kuwait, Qatar and OMAN Of Middle East And Africa
Global Suture Needle Market Germany, Spain, France, United Kingdom, Italy, Eastern-Europe and Rest Of Western Europe Of Europe By Country
Global Suture Needle Market Australia, China, India, Japan, South Korea and Rest Of Asia Pacific By Country
Global Suture Needle Market By Region
Powering the world's best teams.
From next-gen startups to established enterprises.
Trusted by forward-thinking businesses
for data-driven intelligence